GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $250,000 | +88.0% | 1,152 | 0.0% | 0.01% | +30.0% |
| Q4 2020 | $133,000 | +44.6% | 1,152 | +22.3% | 0.01% | +66.7% |
| Q3 2020 | $92,000 | -14.8% | 942 | +6.9% | 0.01% | -25.0% |
| Q2 2020 | $108,000 | +40.3% | 881 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $77,000 | -25.2% | 881 | -10.2% | 0.01% | -12.5% |
| Q4 2019 | $103,000 | +2.0% | 981 | +12.0% | 0.01% | -11.1% |
| Q3 2019 | $101,000 | -33.1% | 876 | 0.0% | 0.01% | -25.0% |
| Q2 2019 | $151,000 | +16.2% | 876 | +13.5% | 0.01% | +9.1% |
| Q1 2019 | $130,000 | +1200.0% | 772 | -22.8% | 0.01% | +1000.0% |
| Q4 2018 | $10,000 | -92.5% | 1,000 | +30.4% | 0.00% | -90.9% |
| Q3 2018 | $133,000 | +54.7% | 767 | -5.8% | 0.01% | +57.1% |
| Q2 2018 | $86,000 | 0.0% | 814 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $86,000 | -21.8% | 814 | -2.4% | 0.01% | -30.0% |
| Q4 2017 | $110,000 | -23.6% | 834 | -41.3% | 0.01% | +11.1% |
| Q3 2017 | $144,000 | +0.7% | 1,420 | 0.0% | 0.01% | -10.0% |
| Q2 2017 | $143,000 | – | 1,420 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |